Business entry of Indian drug companies alerts local industries.

The local pharmaceutical industry keenly alerted to the business entry of the leading Indian pharmaceutical company into Korea, expressing a fear of which local markets might be attacked by far cheaper generic drugs in such a circumstance for the multinational foreign drug corporations to give ever strong pressure with the FTA.

Indian company called "Cipla" and local "D" company may jointly ...